IMMUCELL CORP /DE/ — Director's Dealing 2014

Aug 22, 2014

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: IMMUCELL CORP /DE/ (ICCC)
CIK: 0000811641
Period of Report: 2014-08-19

Reporting Person: ROTHSCHILD JONATHAN E (N/A)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2014-08-19	Common Stock, par value $0.10 per share	P	200.0000	$4.6300	Acquired	510636.0000	Direct
2014-08-19	Common Stock, par value $0.10 per share	P	500.0000	$4.5000	Acquired	511136.0000	Direct
2014-08-19	Common Stock, par value $0.10 per share	P	1000.0000	$4.5100	Acquired	512136.0000	Direct
2014-08-19	Common Stock, par value $0.10 per share	P	500.0000	$4.5000	Acquired	512636.0000	Direct
2014-08-19	Common Stock, par value $0.10 per share	P	200.0000	$4.6300	Acquired	512836.0000	Direct
2014-08-20	Common Stock, par value $0.10 per share	P	200.0000	$4.6100	Acquired	513036.0000	Direct
2014-08-20	Common Stock, par value $0.10 per share	P	200.0000	$4.6600	Acquired	513236.0000	Direct
2014-08-20	Common Stock, par value $0.10 per share	P	200.0000	$4.6000	Acquired	513436.0000	Direct

Footnotes

F1: These shares were acquired by Arterio Inc., a corporation owned soley by Mr. Rothschild

F2: This figure includes 216,255 shares of common stock held by Arterio Inc., a corporation owned soley by Mr. Rothschild and 39,255 shares held by the estate of Mr. Rothschild's parents. Mr. Rothschild is the executor of his parents' estate and is a one-third beneficiary of that estate. The distribution of the assets of that estate has not yet been resolved.